Remove tag policy-solutions
article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. Finding solutions.

article thumbnail

10 Methods in Building Your Pharmacy Website’s Domain Authority – BLOG #75

The Social Pharmacist

Policy on Privacy (Privacy Policy). If you collect a customer’s name, email address, physical address, or location details, add a statement regarding your privacy policy. Strategize Your Internal Linking and Social Tags for Higher Domain Authority Rating. Adding Social Tags to Your Pharmacy Website.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 Methods in Building Your Pharmacy Website’s Domain Authority – BLOG #75

The Social Pharmacist

Policy on Privacy (Privacy Policy). If you collect a customer’s name, email address, physical address, or location details, add a statement regarding your privacy policy. Strategize Your Internal Linking and Social Tags for Higher Domain Authority Rating. Adding Social Tags to Your Pharmacy Website.

HIPAA 40
article thumbnail

DOJ Investigates $250 Million in U.S. Sales of Counterfeit Drugs Using Fake DSCSA Pedigrees

Policy Prescription

If you don’t have access to The Wall Street Journal, then The Star Democrat, a Maryland paper, published a story accessible for free: Cambridge-based Safe Chain Solutions implicated in massive counterfeit HIV drug scheme.] . Safe Chain Pharmacy Solutions. Flaws in the Domestic Drug Supply Chain Don’t Implicate Safe Importation.

FDA 40
article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.